.............. 55 11.2. Prior and Concomitant Medications ................................ ............................... 55 11.3. Permitted Medications ................................ ................................ .................... 55 Prohibited Medications ................................ ................................ .......55 Supportive Care ................................ ................................ .................. 56 11.4. Treatment of Investigational Product Overdose ................................ ............. 56 11.5. Dose Adjustment Criteria ................................ ................................